In Vitro Activities of Moxifloxacin against 900 Aerobic and Anaerobic Surgical Isolates from Patients with Intra-Abdominal and Diabetic Foot Infections-Reference-Cited by-同舟云学术

In Vitro Activities of Moxifloxacin against 900 Aerobic and Anaerobic Surgical Isolates from Patients with Intra-Abdominal and Diabetic Foot Infections

Published:2004-03 Issue:3 Volume:48 Page:1012-1016
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Edmiston Charles E.¹,Krepel Candace J.¹,Seabrook Gary R.¹,Somberg Lewis R.²,Nakeeb Atilla³,Cambria Robert A.¹,Towne Jonathan B.¹

Affiliation:

1. Divisions of Vascular Surgery

2. Trauma and Critical Care

3. Pancreatobiliary Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin

Abstract

ABSTRACT The in vitro activities of moxifloxacin, ciprofloxacin, levofloxacin, gatifloxacin, imipenem, piperacillin-tazobactam, clindamycin, and metronidazole against 900 surgical isolates were determined using NCCLS testing methods. Moxifloxacin exhibited good to excellent antimicrobial activity against most aerobic (90.8%) and anaerobic (97.1%) microorganisms, suggesting that it may be effective for the treatment of polymicrobial surgical infections.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.48.3.1012-1016.2004

Reference23 articles.

1. Ackermann, G., R. Schaumann, B. Pless, M. C. Caros, E. J. C. Goldstein, and C. Rodloff. 2000. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis.19:228-232.

2. Bacteremia Due to Bacteroides fragilis Group: Distribution of Species, β-Lactamase Production, and Antimicrobial Susceptibility Patterns

3. Appelbaum, P. C. 1999. Quinolone activity against anaerobes. Drugs58(Suppl. 2):60-64.

4. Behra-Miellet, J., L. Dubreuil, and E. Jumas-Bilak. 2002. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. Int. J. Antimicrob. Agents20:366-374.

5. Calhoun, J. H., K. A. Overgaard, C. M. Stevens, J. P. Dowling, and J. T. Mader. 2002. Diabetic foot ulcers and infections: current concepts. Adv. Skin Wound Care15:31-42.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials;The Lancet Microbe;2023-11

2. Antibiotic Resistance among Fusobacterium, Capnocytophaga, and Leptotrichia Species of the Oral Cavity;ORAL HLTH PREV DENT;2023

3. Outcomes of Beta-Lactam Allergic and Non-Beta-Lactam Allergic Patients with Intra-Abdominal Infection: A Case–Control Study;Antibiotics;2022-12-09

4. Early Depressing Effect on Abundancy and Diversity of Sputum Microbiome Followed by Recovery During Anti-Tuberculosis Treatment: A Multi-Regimen Analysis of the High-Rifampicin II- and Multi-Arm-Multi-Stage Clinical Trials;SSRN Electronic Journal;2022

5. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis;Antimicrobial Agents and Chemotherapy;2021-10-18